Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and Histiocytic/Dendritic neoplasms. Leukemia 36(7):1703–1719 Epub 2022/06/23. https://doi.org/10.1038/s41375-022-01613-1

Article  PubMed  PubMed Central  Google Scholar 

Kemps PG, Picarsic J, Durham BH, Helias-Rodzewicz Z, Hiemcke-Jiwa L, van den Bos C, van de Wetering MD, van Noesel CJM, van Laar JAM, Verdijk RM, Flucke UE, Hogendoorn PCW, Woei AJF, Sciot R, Beilken A, Feuerhake F, Ebinger M, Mohle R, Fend F, Bornemann A, Wiegering V, Ernestus K, Mery T, Gryniewicz-Kwiatkowska O, Dembowska-Baginska B, Evseev DA, Potapenko V, Baykov VV, Gaspari S, Rossi S, Gessi M, Tamburrini G, Heritier S, Donadieu J, Bonneau-Lagacherie J, Lamaison C, Farnault L, Fraitag S, Jullie ML, Haroche J, Collin M, Allotey J, Madni M, Turner K, Picton S, Barbaro PM, Poulin A, Tam IS, El Demellawy D, Empringham B, Whitlock JA, Raghunathan A, Swanson AA, Suchi M, Brandt JM, Yaseen NR, Weinstein JL, Eldem I, Sisk BA, Sridhar V, Atkinson M, Massoth LR, Hornick JL, Alexandrescu S, Yeo KK, Petrova-Drus K, Peeke SZ, Munoz-Arcos LS, Leino DG, Grier DD, Lorsbach R, Roy S, Kumar AR, Garg S, Tiwari N, Schafernak KT, Henry MM, van Halteren AGS, Abla O, Diamond EL, Emile JF (2022) ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood 139(2):256–280 Epub 2021/11/03. https://doi.org/10.1182/blood.2021013338

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Zheng Y, Xiong Y Imaging features of ALK-positive histiocytosis with neurological involvement: a case report and literature review [Original Research]. Frontiers in Oncology. 2024 2024-February-22;14. English. https://doi.org/10.3389/fonc.2024.1333519

Cheah AL, Zou Y, Lanigan C, Billings SD, Rubin BP, Hornick JL, Goldblum JR (2019) ALK expression in Angiomatoid Fibrous Histiocytoma: a potential diagnostic pitfall. Am J Surg Pathol 43(1):93–101 Epub 2018/06/08. https://doi.org/10.1097/PAS.0000000000001103

Article  PubMed  Google Scholar 

Novello S, Mazieres J, Oh IJ, de Castro J, Migliorino MR, Helland A, Dziadziuszko R, Griesinger F, Kotb A, Zeaiter A, Cardona A, Balas B, Johannsdottir HK, Das-Gupta A, Wolf J (2018) Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study. Ann Oncol 29(6):1409–1416 Epub 2018/04/19. https://doi.org/10.1093/annonc/mdy121

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bauer TM, Shaw AT, Johnson ML, Navarro A, Gainor JF, Thurm H, Pithavala YK, Abbattista A, Peltz G, Felip E (2020) Brain penetration of Lorlatinib: cumulative incidences of CNS and Non-CNS progression with Lorlatinib in patients with previously treated ALK-Positive non-small-cell Lung Cancer. Target Oncol 15(1):55–65 Epub 2020/02/16. https://doi.org/10.1007/s11523-020-00702-4

Article  PubMed  PubMed Central  Google Scholar 

Mousa DV, Mavrovounis G, Argyropoulos D, Stranjalis G, Kalamatianos T (2024) Anaplastic lymphoma kinase (ALK) in posterior cranial Fossa tumors: a scoping review of Diagnostic, Prognostic, and therapeutic perspectives. Cancers (Basel) 16(3). https://doi.org/10.3390/cancers16030650Cited in: Pubmed; PMID 38339401 Epub 2024/02/10

Rigaud C, Knorr F, Brugieres L, Woessmann W (2023) Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents. Best Pract Res Clin Haematol 36(1):101444 Epub 2023/03/13. https://doi.org/10.1016/j.beha.2023.101444

Article  CAS  PubMed  Google Scholar 

Chennouf A, Arslanian E, Roberge D, Berthelet F, Bojanowski M, Bahary JP, Masucci L, Belanger K, Florescu M, Wong P (2017) Efficiency of Crizotinib on an ALK-Positive inflammatory myofibroblastic tumor of the Central Nervous System: a Case Report. Cureus 9(3):e1068 Epub 2017/04/15. https://doi.org/10.7759/cureus.1068

Article  PubMed  PubMed Central  Google Scholar 

Lastowska M, Trubicka J, Karkucinska-Wieckowska A, Kaleta M, Tarasinska M, Perek-Polnik M, Sobocinska AA, Dembowska-Baginska B, Grajkowska W, Matyja E (2019) Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors. Brain Tumor Pathol 36(1):1–6 Epub 2018/12/14. https://doi.org/10.1007/s10014-018-0331-2

Article  CAS  PubMed  Google Scholar